Natural killer (NK) cells are important mediators of anti-tumor immunity and are active against several hematologic malignancies, including multiple myeloma (MM). Umbilical cord blood (CB) is a promising source of allogeneic NK cells but large scale ex vivo expansion is required for generation of clinically relevant CB-derived NK (CB-NK) cell doses. Here we describe a novel strategy for expanding NK cells from cryopreserved CB units using artificial antigen presenting feeder cells (aAPC) in a gas permeable culture system. After 14 days, mean fold expansion of CB-NK cells was 1848-fold from fresh and 2389-fold from cryopreserved CB with.95 % purity for NK cells (CD56+/CD32) and less than 1 % CD3+ cells. Though surface expression of some cyto...
Great interest has been raised recently by the design of new adoptive immunotherapeutic strategies b...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...
Natural killer (NK) cells are important mediators of anti-tumor immunity and are active against seve...
Multiple myeloma (MM) is the second most common hematologic malignancy in adults and, to date, is in...
Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many...
Considering umbilical cord blood (UCB) as a rich source of hematopoietic stem cells, we introduced a...
Contains fulltext : 97724.pdf (publisher's version ) (Open Access)Natural killer (...
Natural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK cells c...
Contains fulltext : 88356.pdf (publisher's version ) (Open Access)Immunotherapy ba...
Natural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK cells c...
AbstractCord blood (CB) natural killer (NK) and lymphokine-activated killer (LAK) cytotoxic cells ar...
AbstractNatural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK...
AbstractRate of immune reconstitution directly correlates with the number of hematopoietic stem cell...
Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for...
Great interest has been raised recently by the design of new adoptive immunotherapeutic strategies b...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...
Natural killer (NK) cells are important mediators of anti-tumor immunity and are active against seve...
Multiple myeloma (MM) is the second most common hematologic malignancy in adults and, to date, is in...
Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many...
Considering umbilical cord blood (UCB) as a rich source of hematopoietic stem cells, we introduced a...
Contains fulltext : 97724.pdf (publisher's version ) (Open Access)Natural killer (...
Natural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK cells c...
Contains fulltext : 88356.pdf (publisher's version ) (Open Access)Immunotherapy ba...
Natural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK cells c...
AbstractCord blood (CB) natural killer (NK) and lymphokine-activated killer (LAK) cytotoxic cells ar...
AbstractNatural killer (NK) cell immunotherapy as a cancer treatment shows promise, but expanding NK...
AbstractRate of immune reconstitution directly correlates with the number of hematopoietic stem cell...
Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for...
Great interest has been raised recently by the design of new adoptive immunotherapeutic strategies b...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...
Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells tha...